For research use only. Not for therapeutic Use.
Apraglutide（Cat No.:I019289）is a synthetic peptide analog designed to mimic the biological activity of naturally occurring glucagon-like peptide-2 (GLP-2). It is specifically engineered to improve gastrointestinal function and is primarily used in the treatment of short bowel syndrome (SBS). Apraglutide works by promoting intestinal growth and enhancing nutrient absorption, thereby reducing the dependency on parenteral nutrition in SBS patients. The drug’s modified peptide structure allows for a prolonged half-life and increased stability, enabling less frequent dosing. Its development represents a significant advancement in therapeutic options for managing complex gastrointestinal disorders.
| Catalog Number | I019289 |
| CAS Number | 1295353-98-8 |
| Molecular Formula | C₁₇₂H₂₆₃N₄₃O₅₂ |
| Purity | ≥95% |
| Target | GLP Receptor |
